Localization of type VI collagen in tissue-engineered cartilage on polymer scaffolds.
Together, the chondrocyte and its pericellular matrix have been collectively termed the chondron. Current opinion is that the pericellular matrix has both protective and signalling functions between chondrocyte and extracellular matrix. Formation of a native chondrocyte pericellular matrix or chondron structure might therefore be advantageous when tissue engineering a functional hyaline cartilage construct. The presence of chondrons has not been previously described in cartilage engineered on a scaffold. In this paper, we describe a modified immunochemical method to detect collagen VI, a key molecular marker for the pericellular matrix, and an investigation of type VI collagen distribution in engineered hyaline cartilage constructs. Cartilage constructs were engineered from adult human or bovine hyaline chondrocytes cultured on sponge or nonwoven fiber based HYAFF 11 scaffolds. Type VI collagen was detected in all constructs, but a distinctive, high-density, chondron-like distribution of collagen VI was present only in constructs exhibiting additional features of hyaline cartilage engineered using nonwoven HYAFF 11. Chondron structures were localized in areas of the extracellular matrix displaying strong collagen II and GAG staining of constructs where type II collagen composed a high percentage (over 65%) of the total collagen.
Centre for Biomaterials and Tissue Engineering, School of Clinical Dentistry, University of Sheffield, United Kingdom.
Sarah A
SA
Fraser
Aileen
A
Crawford
Astrid
A
Frazer
Sally
S
Dickinson
Anthony P
AP
Hollander
Ian M
IM
Brook
Paul V
PV
Hatton
D000818:Animals; D001672:Biocompatible Materials; D002356:Cartilage / Q000378:metabolism*; D002417:Cattle; D019902:Chondrocytes / Q000378:metabolism; D024043:Collagen Type II / Q000378:metabolism; D024142:Collagen Type VI / Q000378:metabolism*; D005109:Extracellular Matrix / Q000378:metabolism; D006025:Glycosaminoglycans / Q000378:metabolism; D006801:Humans; D006820:Hyaluronic Acid / Q000031:analogs & derivatives; D007150:Immunohistochemistry; D008422:Materials Testing; D011108:Polymers; D023822:Tissue Engineering / Q000379:methods*
D001672:Biocompatible Materials; D024043:Collagen Type II; D024142:Collagen Type VI; D006025:Glycosaminoglycans; D011108:Polymers; C086358:hyaluronic acid benzyl ester; D006820:Hyaluronic Acid